Altered permeability and β-lactam resistance in a mutant of mycobacterium smegmatis

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 8, 1997, Pages 1721-1724

  Mukhopadhyay, Sanjay ^a   Chakrabarti, Parul ^a  

^a BOSE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFALORIDINE; CEFALOTIN; CEFAMANDOLE; CEFAZOLIN; CEFOXITIN; GLYCINE; LIPOSOME; PENICILLIN BINDING PROTEIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL WALL; BACTERIUM MUTANT; CONTROLLED STUDY; DRUG PENETRATION; DRUG PROTEIN BINDING; ENZYME ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM SMEGMATIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0030855532     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.8.1721     Document Type: Article

References (26)

1. Basu, J., R. Chattopadhyay, M. Kundu, and P. Chakrabarti. 1992. Purification and characterization of a penicillin-binding protein from Mycobacterium smegmatis. J. Bacteriol. 174:4829-4832.
2. Bloom, B. R., and C. J. L. Murray. 1992. Tuberculosis, commentary on a reemergent killer. Science 257:1332-1338.
3. Brennan, P. J., and H. Nikaido. 1995. The envelope of mycobacteria. Annu. Rev. Biochem. 64:29-63.
4. Casal, M., F. Rodriguez, M. Benavente, and M. Luna. 1986. In vitro susceptibility of Mycobacterium tuberculosis. Mycobacterium fortuitum and Mycobacterium chelonei to augmentin. Eur. J. Clin. Microbiol. 5:453-454.
5. Chambers, H., D. Moreau, D. Yajko, C. Miick, C. Wagner, C. Hackbarth, S. Kocagoz, E. Rosenberg, W. K. Hudley, and H. Nikaido. 1995. Can penicillins be used to treat tuberculosis? Antimicrob. Agents Chemother. 39:2620-2624.
6. Cole, S. T. 1994. Mycobacterium tuberculosis: drug resistance mechanisms. Trends Microbiol. 2:411-415.
7. Fattorini, L., G. Orefici, S. H. Jin, G. Scardaci, G. Amicosante, N. Franceschini, and I. Chopra. 1992. Resistance to β-lactams in Mycobacterium fortuitum. Antimicrob. Agents Chemother. 36:1068-1072.
8. Inderlied, C. 1991. Antimycobacterial agents: in vitro susceptibility testing, spectrums of activity, mechanisms of action and resistance, and assays for activity in biological fluids, p. 134-197. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. The Williams & Wilkins Co., Baltimore, Md.
9. Iseman, M. 1994. Evolution of drug-resistant tuberculosis: a tale of two species. Proc. Natl. Acad. Sci. USA 91:2428-2429.
10. Jarlier, V., L. Gutmann, and H. Nikaido. 1991. Interplay of cell wall barrier and β-lactamase activity determines high resistance to β-lactam antibiotics in Mycobacterium chelonae. Antimicrob. Agents Chemother. 35:1937-1939.
11. Jarlier, V., and H. Nikaido. 1990. Permeability to hydrophilic solutes in Mycobacterium chelonei. J. Bacteriol. 172:1418-1423.
12. Kaneda, S., and K. Yabu. 1983. Purification and some properties of β-lactamase from Mycobacterium smegmatis. Microbiol. Immunol. 27:191-193.
13. Kasik, J. E. 1979. Mycobacterial β-lactamases, p. 339-350. In J. M. T. Hamilton-Miller and J. T. Smith (ed.), Beta-lactamases. Academic Press, Inc. (London) Ltd., London, United Kingdom.
14. Lee, E. H., M. H. Nicolas, M. D. Kitzis, G. Pialoux, E. Collatz, and L. Gutmann. 1991. Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae. J. Gen. Microbiol. 138:2347-2351.
15. Le Minor, L. 1984. Genus III. Salmonella Lignieres 1900, p. 427-458. In N. R. Krieg and J. G. Holt (ed.), Bergey's manual of systematic bacteriology, vol. 1. The Williams & Wilkins Co., Baltimore, Md.
16. Nikaido, H., and E. Y. Rosenberg. 1983. Porin channels in Escherichia coli; studies with liposomes reconstituted from purified proteins. J. Bacteriol. 153:241-252.
17. Nikaido, H., E. Y. Rosenberg, and J. Foulds. 1983. Porin channels in Escherichia coli: studies with β-lactams in intact cells. J. Bacteriol. 133:232-240.
18. Trias, J., and R. Benz. 1993. Characterization of the channel formed by the mycobacterial porin in lipid bilayer membrane. J. Biol. Chem. 268:6234-6240.
19. Trias, J., and R. Benz. 1994. Permeability of the cell wall of Mycobacterium smegmatis. Mol. Microbiol. 14:283-290.
20. Trias, J., V. Jarlier, and R. Benz. 1992. Porins in the cell wall of mycobacteria. Science 258:1479-1481.
21. Watt, B., J. Edwards, A. Rayner, A. Grindey, and G. Harris. 1992. In vitro activity of meropenem and imipenem against mycobacteria: development of a daily antibiotic dosing schedule. Tubercule Lung Dis. 73:134-136.
22. AL, p. 1436-1457. In P. H. A. Sneath, N. S. Mair, M. E. Sharpe, and J. G. Holt (ed.), Bergey's manual of systematic bacteriology, vol. 2. The Williams & Wilkins Co., Baltimore, Md.
23. Wong, C., G. Palmer, and M. Cynamon. 1988. In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium kansasii to amoxicillin and ticarcillin in combination with clavulanic acid. J. Antimicrob. Chemother. 22:863-866.
24. Youmans, G. P., and A. G. Karlson. 1947. Streptomycin sensitivity of tubercle bacilli; studies on recently isolated tubercle bacilli and the development of resistance to streptomycin in vivo. Annu. Rev. Tuberculosis 59:529-534.
25. Zhang, Y., V. Steingrube, and R. Wallace. 1992. Beta lactamase inhibitors and the inducibility of the beta lactamase of Mycobacterium tuberculosis. Am. Rev. Respir. Dis. 145:657-660.
26. Zimmermann, W., and A. Rosselet. 1977. The function of the outer membrane of Escherichia coli as a permeability barrier to β-lactam antibiotics. Antimicrob. Agents Chemother. 12:368-372.